The finished product formulator is highly dependent on the BPC manufacturer to provide bulk substances uniform in chemical and physical characteristics.
(4)Drug productmeans a finished dosage form, for example, tablet, capsule, solution, etc., that contains an active drug ingredient generally, but not necessarily, in association with inactive ingredients.
Pfizer said it would no longer develop its oral weight loss therapy, denuglopron, following a liver industry found in a participant who took part in a study for a once-daily version of the drug.